Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabotegravir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06405464
What this trial is testing

Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures

Who this might be right for
HIV Infections
University of Zurich 600
Not applicableNot Yet RecruitingNCT07402044
What this trial is testing

CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)

Who this might be right for
CABOTEGRAVIRLENACAPAVIR
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 50
Large-scale testing (Phase 3)Study completedNCT02720094
What this trial is testing

Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 4,570
Not applicableUnknownNCT05949203
What this trial is testing

Oregon PrEP at Home Study

Who this might be right for
HIV/AIDS
Oregon Health and Science University 125
Not applicableNot Yet RecruitingNCT07346508
What this trial is testing

Project SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A Nurse-driven Protocol

Who this might be right for
HIV (Human Immunodeficiency Virus)
KC Care Health Center 250
Not applicableNot Yet RecruitingNCT05835635
What this trial is testing

Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine

Who this might be right for
Patient SatisfactionPatient PreferenceQuality of Life+1 more
Pontificia Universidad Catolica de Chile 50
Early research (Phase 1)Study completedNCT05776108
What this trial is testing

Assess the Food Effect and the Relative Bioavailability of the Cabotegravir (CAB) Pediatric Dispersible Tablet (DT) Formulation

Who this might be right for
HIV Infections
ViiV Healthcare 24
Testing effectiveness (Phase 2)Study completedNCT01641809
What this trial is testing

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 244
Not applicableUnknownNCT05697289
What this trial is testing

Satisfaction of HIV-infected Patients Treated With Cabotegravir-rilpivirine Injectable Dual Therapy

Who this might be right for
HIV Infections
Assistance Publique - Hôpitaux de Paris 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06694805
What this trial is testing

Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 326
Testing effectiveness (Phase 2)WithdrawnNCT02462772
What this trial is testing

Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa

Who this might be right for
Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South Africa
Large-scale testing (Phase 3)Study completedNCT04542070
What this trial is testing

Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed

Who this might be right for
HIV Infections
ViiV Healthcare 687
Large-scale testing (Phase 3)Study completedNCT05896761
What this trial is testing

A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 118
Not applicableNot Yet RecruitingNCT06635421
What this trial is testing

The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

Who this might be right for
HIV I Infection
MetroHealth Medical Center 164
Early research (Phase 1)Active Not RecruitingNCT06786520
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults

Who this might be right for
HIV Infections
ViiV Healthcare 69
Not applicableNot Yet RecruitingNCT07637942
What this trial is testing

Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Who this might be right for
HIV -1 Infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 40
Testing effectiveness (Phase 2)WithdrawnNCT06336434
What this trial is testing

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Who this might be right for
HIV-1-infectionPregnancyPostpartum
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableNot Yet RecruitingNCT07438041
What this trial is testing

Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

Who this might be right for
HIVPrEPPrEP Adherence
Westat 272
Early research (Phase 1)Study completedNCT04484337
What this trial is testing

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 138
Early research (Phase 1)Study completedNCT00659191
What this trial is testing

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

Who this might be right for
HIV Infection
GlaxoSmithKline 58
Next Page